Disclosure detail

Basilea Pharmaceutica AG, Allschwil

24.08.2026 · T1Q8O00050

In brief

On 24.08.2026, a person holding the function "Executive member of the board of directors / senior management" at Basilea Pharmaceutica AG, Allschwil disclosed a sale worth CHF 41’250 to SIX Exchange Regulation.

By amount, this ranks #10 of 19 management sales disclosed at Basilea Pharmaceutica AG, Allschwil over the previous 12 months.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

A executive member of the board of directors / senior management of Basilea Pharmaceutica AG, Allschwil declared a "Sale" transaction on 24.08.2026.

SIX publishes the manager's function, never their name: no individual is named in management transactions.

Transaction date24.08.2026

Issuing companyBasilea Pharmaceutica AG, Allschwil

ISINCH0011432447

Transaction sideSale

Management functionExecutive member of the board of directors / senior management

Security typeRegistered shares

Quantity642

Unit priceCHF 64.25

AmountCHF 41’250

ConditionsNet settlement/exersale of 2'500 employee stock options. Strike price CHF 47.60

ExchangeXSWX

Notification IDT1Q8O00050

Other Basilea Pharmaceutica AG, Allschwil insider transactions

These figures aggregate public disclosures. They are not investment advice.